Hrmy earnings
WebHarmony Biosciences Holdings, Inc. (HRMY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate … Web6 apr. 2024 · Harmony Biosciences Holdings, Inc. (HRMY) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts.
Hrmy earnings
Did you know?
Web21 feb. 2024 · Full Year 2024 Financial Results. Net product revenues for the year ended December 31, 2024 were $437.9 million, compared to $305.4 million for 2024. The … Web2 apr. 2024 · Earnings for Harmony Biosciences are expected to grow by 55.23% in the coming year, from $2.39 to $3.71 per share. Harmony Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date …
WebOn Invalid Date, . Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q4 2024 earnings per share (EPS) of $0.82, up 110.26% year over year. Total Harmony Biosciences Holdings earnings for the quarter were $48.51 million.In the same quarter last year, Harmony Biosciences Holdings's earnings per share (EPS) was $0.39. WebOverview Forecast Earnings Dividend Ownership Analyst price target for HRMY All Analysts Top Analysts Based on 6 analyst s offering 12 month price targets for Harmony Biosciences Holdings Inc. Min Forecast $43.00 +40.98% Avg Forecast $60.50 +98.36% Max Forecast $70.00 +129.51% Should I buy or sell HRMY stock? All Analysts Top …
Web1 dag geleden · Earnings Summary For their last quarter, Harmony Biosciences (HRMY) reported earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.54 per share. This reflects a positive... WebHarmony Biosciences Holdings Inc. analyst estimates, including HRMY earnings per share estimates and analyst recommendations.
Web6 apr. 2024 · Harmony Biosciences (NASDAQ:HRMY) has a market capitalization of $1.82 billion and generates $437.86 million in revenue each year. The company earns …
Web21 mrt. 2024 · The price-to-earnings ratio for Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) is above average at 14.83x, Analysts have differing opinions on the stock, with 6 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 … geoff wexlerWeb1 dag geleden · For their last quarter, Harmony Biosciences (HRMY) reported earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.54 per share. This reflects … chris nordbyWebHarmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 42.50% and 7.73%, respectively, for the quarter ended June 2024. geoff westrichWeb31 mrt. 2024 · Is Harmony Biosciences (NASDAQ:HRMY) the best stock in the Pharmaceutical preparations industry? Compare top HRMY competitors at MarketBeat. Skip to main content. S&P 500 (+1.33%) DOW (+1.14%) ... institutional ownership, community ranking, earnings, media sentiment, analyst recommendations, risk, dividends and … chris norburyWebHRMY: Harmony Biosciences Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. chris noonan moviesWebTable displays both upcoming quarterly earnings dates and historical release dates. ... (HRMY). Stocks Features Premarket Trading After Hours Trading Market Movers 52-Week Highs & Lows Stock Order Imbalance Unusual Stock … geoff wetrosky hrcWebUpgrade to Premium to see how . HRMY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. Try It for Just $1. ... HRMY price to earnings (PE)For valuing profitable companies with steady earnings. Company. 10.87x. Industry. 18.17x. Market. 21.81x. chris nordin